Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>I tally xx - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.</li>
<li>No new deals were discussed on Smartkarma this week. <a href="https://www.smartkarma.com/entities/z-fin-limited" target="_blank" data-smartkarma-citation="entities:9999:1" rel="noopener">Z Fin (1168 HK)</a> is suspended pursuant to the Takeovers Code. </li>
<li>Key updates/news also took place on: <a href="https://www.smartkarma.com/entities/perpetual-ltd" target="_blank" data-smartkarma-citation="entities:599:1" rel="noopener">Perpetual Ltd (PPT AU)</a>, <a href="https://www.smartkarma.com/entities/vault-minerals-ltd" target="_blank" data-smartkarma-citation="entities:46317:1" rel="noopener">Vault Minerals Ltd (VAU AU)</a>, <a href="https://www.smartkarma.com/entities/accent-group-ltd" target="_blank" data-smartkarma-citation="entities:14283:1" rel="noopener">Accent Group (AX1 AU)</a>, <a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a>, and <a href="https://www.smartkarma.com/entities/avarga-limited" target="_blank" data-smartkarma-citation="entities:13105:1" rel="noopener">Avarga (AVARGA SP)</a>.</li>
</ul>


I tally xx - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.
No new deals were discussed on Smartkarma this week. Z Fin (1168 HK) is suspended pursuant to the Takeovers Code. 
Key updates/news also took place on: Perpetual Ltd (PPT AU), Vault Minerals Ltd (VAU AU), Accent Group (AX1 AU), Steadfast (SDF AU), and Avarga (AVARGA SP).


Asia-Pac Weekly Wrap: Perpetual, Vault Minerals, Accent Group, Steadfast, Avarga, Z Fin,

<ul>
<li>For June 2026, just six new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$6bn.</li>
<li>The average premium for the new transactions announced (or first discussed) in June was ~38.5%, and a year-to-date average of 47%.</li>
<li>The average premiums for transactions in 2025, 2024, 2023, 2022, 2021, 2020, and 2019 were 49%, 43%, 39%, 41%, 33%, 31%, and 31%.</li>
</ul>


For June 2026, just six new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$6bn.
The average premium for the new transactions announced (or first discussed) in June was ~38.5%, and a year-to-date average of 47%.
The average premiums for transactions in 2025, 2024, 2023, 2022, 2021, 2020, and 2019 were 49%, 43%, 39%, 41%, 33%, 31%, and 31%.


Asia-Pac M&A [June 2026 Wrap]: Steadfast, Con Aero Tech, Accent, Cygnus, Ajinomoto Malaysia

<ul>
<li>I tally 33 - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.</li>
<li>One new deal was discussed on Smartkarma this week: <a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a>'s NBIO. Arguably <a href="https://www.smartkarma.com/entities/continental-aerospace-technologies-holding-ltd" target="_blank" data-smartkarma-citation="entities:15249:1" rel="noopener">Continental Aerospace Technologies (232 HK)</a> is a pseudo arb.</li>
<li>Key updates/news also took place on <a href="https://www.smartkarma.com/entities/atlas-arteria-ltd" target="_blank" data-smartkarma-citation="entities:14430:1" rel="noopener">Atlas Arteria (ALX AU)</a>, <a href="https://www.smartkarma.com/entities/ooh-media-ltd" target="_blank" data-smartkarma-citation="entities:8662:1" rel="noopener">oOh!Media Ltd (OML AU)</a>, <a href="https://www.smartkarma.com/entities/nippon-dry-chemical-co-ltd" target="_blank" data-smartkarma-citation="entities:13528:1" rel="noopener">Nippon Dry Chemical (1909 JP)</a>, and <a href="https://www.smartkarma.com/entities/monash-ivf-group-ltd" target="_blank" data-smartkarma-citation="entities:18130:1" rel="noopener">Monash IVF (MVF AU)</a>.</li>
</ul>


I tally 33 - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.
One new deal was discussed on Smartkarma this week: Steadfast (SDF AU)'s NBIO. Arguably Continental Aerospace Technologies (232 HK) is a pseudo arb.
Key updates/news also took place on Atlas Arteria (ALX AU), oOh!Media Ltd (OML AU), Nippon Dry Chemical (1909 JP), and Monash IVF (MVF AU).


Asia-Pac Weekly Wrap:Steadfast, Con Aero Tech, Atlas Arteria, OOh!Media, Nippon Dry Chem, Monash IVF

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a> disclosed a non-binding proposal from Amwins and Dragoneer at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.</li>
<li>While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with precedent transactions. </li>
<li>Regulatory approvals are low-risk, and the shareholder structure reduces the scheme voting risk. However, the NBIO could trigger a competing offer. </li>
</ul>



Steadfast (SDF AU) disclosed a non-binding proposal from Amwins and Dragoneer at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.
While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with precedent transactions. 
Regulatory approvals are low-risk, and the shareholder structure reduces the scheme voting risk. However, the NBIO could trigger a competing offer. 


Steadfast (SDF AU): Amwins and Dragoneer’s NBIO at A$6.00

<ul>
<li>As discussed in <a href="https://www.smartkarma.com/compose/insight/242389/Steadfast%20(SDF%20AU):%20Suitors%20Circle%20As%20Share%20Price%20Languishes%20After%20Internal%20Complaint" target="_blank" rel="noopener">Steadfast (SDF AU): Suitors Circle As Share Price Languishes After Internal Complaint</a>,  insurance play <a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a> was reportedly attracting PE interest, such as Blackstone. </li>
<li>Steadfast has now entered into a process deal with Amwins and Dragoneer at A$6/share by way of a Scheme, a 51.9% premium to undisturbed.</li>
<li>Amwins/Dragoneer have been provided with eight weeks of exclusive due diligence access. A firm Offer will requires FIRB and OIO signing off. </li>
</ul>


As discussed in Steadfast (SDF AU): Suitors Circle As Share Price Languishes After Internal Complaint,  insurance play Steadfast (SDF AU) was reportedly attracting PE interest, such as Blackstone. 
Steadfast has now entered into a process deal with Amwins and Dragoneer at A$6/share by way of a Scheme, a 51.9% premium to undisturbed.
Amwins/Dragoneer have been provided with eight weeks of exclusive due diligence access. A firm Offer will requires FIRB and OIO signing off. 


Steadfast (SDF AU): Amwins' (Possibly Opportunistic) A$6/Share NBIO

Australia

Steadfast Group Ltd is a provider of services to broker businesses across Australia, New Zealand and Singapore. The Company has equity interests in insurance broker businesses, underwriting agencies and other complementary businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Steadfast (SDF AU)

Asia-Pac Weekly Wrap: Perpetual, Vault Minerals, Accent Group, Steadfast, Avarga, Z Fin,

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Asia-Pac M&A [June 2026 Wrap]: Steadfast, Con Aero Tech, Accent, Cygnus, Ajinomoto Malaysia

The average premium for the new transactions announced (or first discussed) in June was ~38.5%, and a year-to-date average of 47%.

David Blennerhassett

Asia-Pac Weekly Wrap:Steadfast, Con Aero Tech, Atlas Arteria, OOh!Media, Nippon Dry Chem, Monash IVF

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Steadfast (SDF AU): Amwins and Dragoneer’s NBIO at A$6.00

While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Asia-Pac Weekly Wrap: Perpetual, Vault Minerals, Accent Group, Steadfast, Avarga, Z Fin,

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Asia-Pac M&A [June 2026 Wrap]: Steadfast, Con Aero Tech, Accent, Cygnus, Ajinomoto Malaysia

The average premium for the new transactions announced (or first discussed) in June was ~38.5%, and a year-to-date average of 47%.

David Blennerhassett

Asia-Pac Weekly Wrap:Steadfast, Con Aero Tech, Atlas Arteria, OOh!Media, Nippon Dry Chem, Monash IVF

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Steadfast (SDF AU): Amwins and Dragoneer’s NBIO at A$6.00

While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with...

Arun George

Steadfast (SDF AU): Amwins' (Possibly Opportunistic) A$6/Share NBIO

Indicative terms appear attractive; but on par with late-Oct 2025 levels when a workplace complaint emerged against the CEO. Terms are not firm. I...

David Blennerhassett